Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815–1822
Andreeva ER, Grigorieva OV, Andrianova IV, Gornostaeva AN, Buravkova LB (2012) Human stromal and blood-born cells interaction under different O2 tension. part I. Immunocupressive effects. Technol Living Syst 9:13–18
Ankrum JA, Ong JF, Karp JM (2014) Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol 32:252–260
Bartholomew A, Sturgeon C, Siatskas M et al (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42–48
Benvenuto F, Ferrari S, Gerdoni E et al (2007) Human mesenchymal stem cells promote survival of T cells in a quiescent state. Stem Cells 25:1753–1760
Buravkova LB, Grinakovskaia OS, Andreeva EP, Zhambalova AP, Kozionova MP (2009) Characteristics of human lipoaspirate-isolated mesenchymal stromal cells cultivated under a lower oxygen tension. Tsitologiia 51:5–11
Cappellesso-Fleury S, Puissant B, Apoil PA et al (2010) Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol 30:607–619
Carrade Holt DD, Wood JA, Granick JL et al (2014) Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source. Stem Cells Dev 23:1258–1265
Chabannes D, Hill M, Merieau E et al (2007) A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 110:3691–3694
Corcione A, Benvenuto F, Ferretti E et al (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107:367–372
Crop M, Baan CC, Korevaar SS et al (2010) Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation. Stem Cells Dev 19:1843–1853
Deng W, Han Q, Liao L et al (2005) Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. DNA Cell Biol 24:458–463
Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. Cytotherapy 8:315–317
Engela AU, Baan CC, Dor Frank JMF et al (2012) On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation. Front Immunol 3:126–134
Fehrer C, Brunauer R, Laschober G et al (2007) Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 6:745–757
Francois M, Romieu-Mourez R, Li M, Galipeau J (2012) Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 20:187–195
Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393–403
Glennie S, Soeiro I, Dyson PJ et al (2005) Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105:2821–2827
Gornostaeva AN, Andreeva ER, Andrianova IV, Buravkova LB (2011) Immunosuppressive effects of multipotent mesenchymal stromal cells in cultures with different O2 content in the medium. Bull Exp Biol Med 151:526–529
Gornostaeva AN, Andreeva ER, Buravkova LB (2013) Human MMSC immunosuppressive activity at low oxygen tension: direct cell-to-cell contacts and paracrine regulation. Hum Physiol 39:31–42
Grayson WL, Zhao F, Bunnell B, Ma T (2007) Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 358:948–953
Grigoryan AS, Tsupkina NV, Sergeev VS et al (2007) Characterization of bone marrow stromal cells in the mixed lymphocyte reaction. Cell Transplantol Tissue Eng 2:62–66
Groh ME, Maitra B, Szekely E, Koc ON (2005) Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 33:928–934
Huang XP, Sun Z, Miyagi Y et al (2010) Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 122:2419–2429
Ja Friedenstein A, Luria EA (1980) Cellular bases of hemopoietic microenviroment. Meditsina, Moscow
Jarvinen L, Badri L, Wettlaufer S et al (2008) Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J Immunol. 181:4389–4396
Jiang XX, Zhang Y, Liu B et al (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120–4126
Jones BJ, McTaggart J (2008) Immunosuppression by mesenchymal stromal cells: From culture to clinic. Exp Hematol 36:733–741
Kim JH, Lee YT, Hong JM, Hwang YI (2013) Suppression of in vitro murine T cell proliferation by human adipose tissue-derived mesenchymal stem cells is dependent mainly on cyclooxygenase-2 expression. Anat Cell Biol 46:262–271
Kim DS, Lee MW, Yoo KH et al (2014) gene expression profiles of human adipose tissue-derived mesenchymal stem cells are modified by cell culture density. PLoS One 9:e83363. doi: 10.1371/journal.pone.0083363
Krampera M, Cosmi L, Angeli R et al (2006) Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386–398
Kronsteiner B, Wolbank S, Peterbauer A et al (2011) Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells. Stem Cells Dev 20:2115–2126
Le Blanc K, Tammik C, Rosendahl K et al (2003a) b) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890–896
Le Blanc K, Tammik L, Sundberg B et al (2003b) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57:11–20
Le Blanc K, Rasmusson I, Gotherstrom C et al (2004) Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 60:307–315
Le Blanc K, Frassoni F, Ball L et al (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579–1586
Lee MW, Kim DS, Ryu S et al (2013) Effect of ex vivo culture conditions on immunosuppression by human mesenchymal stem cells. Biomed Res Int 2013:154919. doi: 10.1155/2013/154919
Lin CS, Lin G, Lue TF (2012) Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev 12:2770–2778
Maccario R, Podesta M, Moretta A et al (2005) Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4 + T-cell subsets expressing a regulatory/suppressive phenotype. Stem Cell Transplant Haematol 90:516–525
Mcintosh K, Zvonic S, Garrett S et al (2006) The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 24:1246–1253
Meisel R, Zibert A, Laryea M et al (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation. Blood 103:4619–4621
Nauta AJ, Kruisselbrink AB, Lurvink E et al (2006) Mesenchymal stem cells inhibit generation and function of both CD34-derived and monocyte-derived dendritic cells. J Immunol 177:2080–2087
Nekanti U, Dastidar S, Venugopal P et al (2010) Increased proliferation and analysis of differential gene expression in human wharton’s jelly-derived mesenchymal stromal cells under hypoxia. Cell 6:499–512
Niemeyer P, Vohrer J, Schmal H et al (2008) Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice. Cytotherapy 10:784–795
Park MJ, Shin JS, Kim YH et al (2011) Murine mesenchymal stem cells suppress T lymphocyte activation through IL-2 receptor α (CD25) cleavage by producing matrix metalloproteinases. Stem Cell Rev 7:381–393
Pigotta JH, Ishiharaa A, Wellmanb ML et al (2013) Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses. Vet Immunol Immunopathol 156:99–106
Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB (2010) Pro-Inflammatory cytokines, IFNγ and TNFa, influence immune properties of human bone marrow and wharton jelly mesenchymal stem cells differentially. PLoS One 5:e9016
Puissant B, Barreau C, Bourin P et al (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129:118–129
Quaedackers ME, Baan CC, Weimar W, Hoogduijn MJ (2009) Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes. Eur J Immunol 39:3436–3446
Ramasamy R, Tong CK, Seow HF et al (2008) The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T-cell proliferation but not its effector function. Cell Immunol 251:131–136
Ren G, Su J, Zhang L et al (2009) Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27:1954–1962
Ryan JM, Barry F, Murphy JM, Mahon BP (2007) Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149:353–363
Saldanha-Araujo F, Haddad R, Kelen CR et al (2012) Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-kB signaling. J Cell Mol Med 16:1232–1244
Selmani Z, Naji A, Zidi I et al (2008) Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress t lymphocyte and natural killer function and to induce CD4-CD25 high FOXP3- regulatory T cells. Stem Cells 26:212–222
Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G (2012) How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 33:136–143
Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M (2006) Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24:74–85
Spaggiari GM, Capobianco A, Becchetti S et al (2006) Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107:1484–1490
Suva D, Passweg J, Arnaudeau S et al (2008) In vitro activated human t lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them. J Cell Physiol 214:588–594
Tasso R, Ilengo C, Quarto R et al (2012) Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 53:786–793
Yang SH, Park MJ, Yoon IH et al (2009) Soluble mediators from mesenchymal stem cells supress T cell proliferation by inducing IL-10. Exp Mol Med 41:315–324